Hepatitis C virus and the lung: implications for therapy.
about
Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.Complement and viral pathogenesisHepatitis C virus infection is not an independent risk factor for obstructive lung disease.Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3.Pulmonary complications in cirrhotic candidates for liver transplantationBrief Report: Coordinated Modulation of Circulating miR-21 in HIV, HIV-Associated Pulmonary Arterial Hypertension, and HIV/Hepatitis C Virus Coinfection.Trends in Epidemiology of COPD in HIV-Infected Patients in Spain (1997-2012).Venous outflow obstruction and portopulmonary hypertension after orthotopic liver transplantation.Genomics of pulmonary arterial hypertension: implications for therapy.Viral infection and pulmonary hypertension: is there an association?Diagnostic workup for diffuse parenchymal lung disease: schematic flowchart, literature review, and pitfalls.Pharmacological treatment of HIV-associated pulmonary hypertension.Drug-induced lung injury associated with sorafenib: analysis of all-patient post-marketing surveillance in Japan.Prevalence of hepatitis C virus infection in patients with COPD.Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin.Hepatitis C: the complications of immune dysfunction.Pathology of pulmonary hypertension
P2860
Q30397068-2C47FB3F-F9C5-4D0C-987D-01F5157BDC42Q34162421-F906FBB2-2975-470E-AE45-74FE80D7FFB0Q34998846-4AA373CA-735F-4704-9867-A5EF2F0E89BCQ35220326-05C353D2-39A2-4383-BC39-29A5E6459AB9Q35724569-417FE94A-393F-4636-8365-128BAA7FDDC8Q36175085-220B501B-2DDF-4B35-81CA-9E14E14E920BQ36192956-7E992463-7C2F-4F25-A8EB-008ED7B7116BQ37178554-BA710A92-1D39-4C32-94A2-E44779E91A98Q37452405-3C41FB26-B2F9-4CB5-9F89-43DDE24E7524Q37867671-62699E8D-D986-450E-91F3-388731BFF6FFQ38059610-BDF67F3B-DD0A-4453-8E27-25D82D765115Q38728500-B25474A6-53F6-421A-8B4D-A9553DF84B39Q40281727-8E4C5546-5F45-4282-B025-4022996D16CFQ42989000-3DBBC285-C6CD-47CD-86BF-E960032CB709Q45352196-79BDA51B-7F2A-4FBB-AB1B-FFDBD26636BFQ47580213-BF568AC6-ACB2-45DC-87AA-98B77557B0ADQ56388717-1D22D497-705F-4C80-BA0C-D5512CC1DA63
P2860
Hepatitis C virus and the lung: implications for therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Hepatitis C virus and the lung: implications for therapy.
@ast
Hepatitis C virus and the lung: implications for therapy.
@en
type
label
Hepatitis C virus and the lung: implications for therapy.
@ast
Hepatitis C virus and the lung: implications for therapy.
@en
prefLabel
Hepatitis C virus and the lung: implications for therapy.
@ast
Hepatitis C virus and the lung: implications for therapy.
@en
P2093
P356
P1433
P1476
Hepatitis C virus and the lung: implications for therapy.
@en
P2093
Guha Krishnaswamy
Jonathan Moorman
Mustafa Saad
Semaan Kosseifi
P304
P356
10.1378/CHEST.128.4.2882
P407
P577
2005-10-01T00:00:00Z